Compare CLDT & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDT | NBY |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.9M | 398.2M |
| IPO Year | N/A | 2007 |
| Metric | CLDT | NBY |
|---|---|---|
| Price | $7.76 | $1.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | 281.8K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | $1.29 | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | $610.21 | ★ $1.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.83 | $0.43 |
| 52 Week High | $8.45 | $19.95 |
| Indicator | CLDT | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 41.60 |
| Support Level | $6.81 | $0.99 |
| Resistance Level | N/A | $1.36 |
| Average True Range (ATR) | 0.29 | 0.26 |
| MACD | 0.03 | 0.22 |
| Stochastic Oscillator | 45.06 | 33.21 |
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.